Gwo Xi Stem Cell Applied Technology Co. , Ltd (TPEX:6704)
30.00
-0.05 (-0.17%)
Sep 26, 2025, 2:40 PM CST
TPEX:6704 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
184.91 | 170.03 | 141.18 | 180.67 | 242.75 | 188.54 | Upgrade | |
Revenue Growth (YoY) | 22.87% | 20.44% | -21.86% | -25.57% | 28.75% | 6.71% | Upgrade |
Cost of Revenue | 56.49 | 53.38 | 44.4 | 25.86 | 45.68 | 21.49 | Upgrade |
Gross Profit | 128.43 | 116.64 | 96.77 | 154.81 | 197.07 | 167.05 | Upgrade |
Selling, General & Admin | 91.3 | 81.91 | 82.78 | 160.54 | 203.38 | 152.29 | Upgrade |
Research & Development | 99.9 | 110.67 | 108.17 | 109.16 | 95.11 | 86.83 | Upgrade |
Operating Expenses | 191.31 | 192.58 | 190.73 | 270.1 | 296.49 | 241.44 | Upgrade |
Operating Income | -62.88 | -75.93 | -93.96 | -115.29 | -99.42 | -74.4 | Upgrade |
Interest Expense | -10.91 | -11.43 | -12.36 | -1.96 | -1.67 | -1.34 | Upgrade |
Interest & Investment Income | 3.58 | 3.92 | 1.62 | 0.26 | 0.07 | 0.15 | Upgrade |
Currency Exchange Gain (Loss) | -0.06 | 0 | -0.02 | 0.05 | -0.03 | 0.07 | Upgrade |
Other Non Operating Income (Expenses) | 0.13 | 0.13 | 1.69 | 0.94 | 3.23 | 5.63 | Upgrade |
EBT Excluding Unusual Items | -70.14 | -83.31 | -103.03 | -116 | -97.83 | -69.89 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.59 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | 15.88 | 4.86 | - | -1.51 | Upgrade |
Other Unusual Items | - | - | - | 0.21 | 0.89 | 0.2 | Upgrade |
Pretax Income | -70.14 | -83.31 | -87.15 | -110.94 | -96.94 | -71.78 | Upgrade |
Income Tax Expense | - | 0.01 | 0.94 | 0.68 | 5.81 | 2.78 | Upgrade |
Earnings From Continuing Operations | -70.14 | -83.32 | -88.09 | -111.61 | -102.74 | -74.56 | Upgrade |
Minority Interest in Earnings | - | - | - | -0.49 | -3.5 | - | Upgrade |
Net Income | -70.14 | -83.32 | -88.09 | -112.11 | -106.24 | -74.56 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | - | - | 0.69 | - | Upgrade |
Net Income to Common | -70.14 | -83.32 | -88.09 | -112.11 | -106.93 | -74.56 | Upgrade |
Shares Outstanding (Basic) | 96 | 96 | 90 | 85 | 83 | 81 | Upgrade |
Shares Outstanding (Diluted) | 96 | 96 | 90 | 85 | 83 | 81 | Upgrade |
Shares Change (YoY) | 2.51% | 7.12% | 4.86% | 3.04% | 2.86% | 6.22% | Upgrade |
EPS (Basic) | -0.73 | -0.87 | -0.98 | -1.31 | -1.29 | -0.93 | Upgrade |
EPS (Diluted) | -0.73 | -0.87 | -0.98 | -1.31 | -1.29 | -0.96 | Upgrade |
Free Cash Flow | -84.22 | -75.3 | -17.79 | -81.88 | -72.34 | -184.29 | Upgrade |
Free Cash Flow Per Share | -0.88 | -0.79 | -0.20 | -0.96 | -0.87 | -2.29 | Upgrade |
Gross Margin | 69.45% | 68.60% | 68.55% | 85.69% | 81.18% | 88.60% | Upgrade |
Operating Margin | -34.01% | -44.66% | -66.55% | -63.81% | -40.96% | -39.46% | Upgrade |
Profit Margin | -37.93% | -49.00% | -62.40% | -62.05% | -44.05% | -39.55% | Upgrade |
Free Cash Flow Margin | -45.55% | -44.28% | -12.60% | -45.32% | -29.80% | -97.75% | Upgrade |
EBITDA | -9.88 | -23.4 | -41.3 | -64.45 | -74.74 | -59.22 | Upgrade |
EBITDA Margin | -5.34% | -13.76% | -29.25% | -35.67% | -30.79% | -31.41% | Upgrade |
D&A For EBITDA | 53.01 | 52.53 | 52.66 | 50.84 | 24.68 | 15.18 | Upgrade |
EBIT | -62.88 | -75.93 | -93.96 | -115.29 | -99.42 | -74.4 | Upgrade |
EBIT Margin | -34.01% | -44.66% | -66.55% | -63.81% | -40.96% | -39.46% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.